Pouya Safarzadeh Kozani

发表

Nanobody-based CAR-T cells for cancer immunotherapy

A. Naseri, M. Nikbakht, Pouya Safarzadeh Kozani, 2022, Biomarker research.

Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

F. Yousefi, F. Rahbarizadeh, Pouya Safarzadeh Kozani, 2022, Frontiers in Immunology.

Novel antigens of CAR T cell therapy: New roads; old destination

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Translational oncology.

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Stem Cell Research & Therapy.

CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2022, Frontiers of Medicine.

Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Critical reviews in biotechnology.

Chimeric Antigen Receptor T-Cell Therapy: An Overview of the Changing Face of Cancer Immunotherapy

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Trends in Medical Sciences.

CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study.

M. Shokrgozar, Mehryar Habibi Roudkenar, Pouya Safarzadeh Kozani, 2022, International immunopharmacology.

ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review

N. Baharifar, Pouya Safarzadeh Kozani, Seyed Mohamad Javad Mirarefin, 2022, Trends in Medical Sciences.

Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s

A. Sheikhi, A. Naseri, Pouya Safarzadeh Kozani, 2021, Trends in Medical Sciences.

Directional capacity of Human Mesenchymal Stem Cells to support Hematopoietic Stem Cell proliferation in vitro.

R. Ramasamy, K. Ling, Pouya Safarzadeh Kozani, 2022, Gene.

Strategies for Dodging the Obstacles in CAR T Cell Therapy

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Frontiers in Oncology.

CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2022, Frontiers of Medicine.

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

F. Nasiri, Pouya Safarzadeh Kozani, Seyed Mohamad Javad Mirarefin, 2022, Frontiers in Immunology.

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia

F. Rahbarizadeh, E. Kamali, Pouya Safarzadeh Kozani, 2020, Medical Oncology.

In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL

Roddy S. O’Connor, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Molecular Cancer Therapeutics.

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Frontiers in Immunology.

Bebtelovimab: The FDA-approved Monoclonal Antibody for Treating Patients with Mild-to-Moderate COVID-19

N. Baharifar, Pouya Safarzadeh Kozani, Seyed Mohamad Javad Mirarefin, 2022, Trends in Medical Sciences.

Polysaccharide-based hydrogels: properties, advantages, challenges, and optimization methods for applications in regenerative medicine

Masoud Hamidi, Mehdi Jaymand, Pouya Safarzadeh Kozani, 2021, International Journal of Polymeric Materials and Polymeric Biomaterials.

The Potential Applicability of Single-Domain Antibodies (VHH): From Checkpoint Blockade to Infectious Disease Therapy

Fatemeh Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021 .

Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Trends in Medical Sciences.

Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021 .

Promoting the Effector Function of Natural Killer (NK) Cells with a Focus on Bispecific Redirecting Antibodies

A. Sheikhi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Trends in Medical Sciences.

Flexible Aptamer-Based Nucleolin-Targeting Cancer Treatment Modalities: A Focus on Immunotherapy, Radiotherapy, and Phototherapy

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2021, Trends in Medical Sciences.

Tebentafusp: The First FDA-approved Monoclonal Antibody for Cancer Treatment in 2022

Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, A. Sheikhi, 2022, Trends in Medical Sciences.

CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer

Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Setareh Dashti Shokoohi, 2023, Frontiers in immunology.

Humanization of the antigen-recognition domain does not impinge on the antigen-binding, cytokine secretion, and antitumor reactivity of humanized nanobody-based CD19-redirected CAR-T cells

F. Rahbarizadeh, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, 2024, Journal of translational medicine.